| |
Newsroom /
Medical
/
Medical
/
Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts
Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts
The Global Neurostimulation Devices Market is Forecast to Reach $4.7 Billion by 2017, The report provides market landscape, competitive landscape and market trends information on the neurostimulation devices market.
Hyderabad,
AP,
India
(prbd.net)
08/06/2011
The global neurostimulation devices market was valued at $1.8 billion in 2010 and is expected to grow at a compound annual growth rate (CAGR) of 14% to reach $4.7 billion by 2017. The spinal cord stimulation (SCS) devices market is the largest segment of the neurostimulation devices market. The SCS devices market accounted for $1,089m in 2010 and is estimated to grow at a CAGR of 15% to reach $2,819m in 2017. The neurostimulation devices market is poised for rapid growth as a lot of research is being undertaken on neurostimulation therapy for the treatment of various indications, such as Parkinson’s disease, chronic pain, epilepsy, and depression. The introduction of more technologically advanced neurostimulation devices and the growing disease prevalence and incidence is expected to drive growth in the future.
For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Neurostimulation-Devices-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report
The rise in research and development (R&D) in this segment, as well as rising healthcare spending, will
further encourage innovation in this field. The increasing elderly population and consequent rise in
disease incidence will compound the growing demand for newer and more advanced neurostimulation
devices. The neurostimulation devices segment has a strong pipeline, with a number of companies
engaged in the development of innovative neurostimulator products. Support from regulatory bodies
including the FDA (Food and Drug Administration) will also drive investment in the neurostimulation
devices market, which will result in the development of improved and more efficient neurostimulators.
The US is the largest market in the neurostimulation devices segment with about a 70% share of global
sales. The neurostimulation devices market in the US was valued at $1,300m in 2010. It is estimated to
grow at a CAGR of 15% to reach $3,524m in 2017.
GlobalData’s new report, “Neurostimulation Devices - Global Pipeline Analysis, Competitive
Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global
neurostimulation devices market. The report provides market landscape, competitive landscape and
market trends information on the neurostimulation devices market. The report provides comprehensive
information on the key trends affecting the market, and key analytical content on the market dynamics.
The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Neurostimulation-Devices-Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017&Title=Medical_Devices&ReportType=Industry_Report
Visit our report store: http://www.globaldata.com
For more details contact:
pressreleases@globaldata.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782
About
GlobalData is a global market intelligence services company providing information research and analysis products and services.
|